These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 1635029

  • 1. Binding of complement to trypomastigotes of a Brazil strain of Trypanosoma cruzi: evidence for heterogeneity within the strain.
    Jacobson KC, Washburn RG, Kuhn RE.
    J Parasitol; 1992 Aug; 78(4):697-704. PubMed ID: 1635029
    [Abstract] [Full Text] [Related]

  • 2. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement.
    Tomlinson S, Pontes de Carvalho LC, Vandekerckhove F, Nussenzweig V.
    J Immunol; 1994 Oct 01; 153(7):3141-7. PubMed ID: 8089492
    [Abstract] [Full Text] [Related]

  • 3. Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: dependence on the developmentally regulated synthesis of surface protein and N-linked carbohydrate.
    Sher A, Hieny S, Joiner K.
    J Immunol; 1986 Nov 01; 137(9):2961-7. PubMed ID: 3531342
    [Abstract] [Full Text] [Related]

  • 4. Binding of C3 fragments to the Trypanosoma cruzi surface in the absence of specific antibodies and without activation of the complement cascade.
    Krettli AU, Pontes de Carvalho LC.
    Clin Exp Immunol; 1985 Nov 01; 62(2):270-7. PubMed ID: 3910312
    [Abstract] [Full Text] [Related]

  • 5. Lytic rabbit IgG for tissue culture trypomastigotes of Trypanosoma cruzi alters the extent and form of complement deposition.
    Rimoldi MT, Tartanian A, Joiner KA.
    Exp Parasitol; 1989 Feb 01; 68(2):160-7. PubMed ID: 2647504
    [Abstract] [Full Text] [Related]

  • 6. Relative resistance of Brazil strain trypomastigote forms of Trypanosoma cruzi to in vitro antibody-dependent complement-mediated lysis.
    Murfin DJ, Kuhn RE.
    J Parasitol; 1988 Dec 01; 74(6):1046-50. PubMed ID: 3057163
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor.
    Norris KA, Bradt B, Cooper NR, So M.
    J Immunol; 1991 Oct 01; 147(7):2240-7. PubMed ID: 1717552
    [Abstract] [Full Text] [Related]

  • 12. Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.
    Joiner K, Sher A, Gaither T, Hammer C.
    Proc Natl Acad Sci U S A; 1986 Sep 01; 83(17):6593-7. PubMed ID: 2944112
    [Abstract] [Full Text] [Related]

  • 13. Trypanosoma cruzi: characterization of an intracellular epimastigote-like form.
    Almeida-de-Faria M, Freymüller E, Colli W, Alves MJ.
    Exp Parasitol; 1999 Aug 01; 92(4):263-74. PubMed ID: 10425154
    [Abstract] [Full Text] [Related]

  • 14. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages.
    Camargo MM, Almeida IC, Pereira ME, Ferguson MA, Travassos LR, Gazzinelli RT.
    J Immunol; 1997 Jun 15; 158(12):5890-901. PubMed ID: 9190942
    [Abstract] [Full Text] [Related]

  • 15. Amastigote and epimastigote stage-specific components of Trypanosoma cruzi characterized by using monoclonal antibodies. Purification and molecular characterization of an 83-kilodalton amastigote protein.
    Pan AA, McMahon-Pratt D.
    J Immunol; 1989 Aug 01; 143(3):1001-8. PubMed ID: 2501384
    [Abstract] [Full Text] [Related]

  • 16. Developmentally regulated expression by Trypanosoma cruzi of molecules that accelerate the decay of complement C3 convertases.
    Rimoldi MT, Sher A, Heiny S, Lituchy A, Hammer CH, Joiner K.
    Proc Natl Acad Sci U S A; 1988 Jan 01; 85(1):193-7. PubMed ID: 3277170
    [Abstract] [Full Text] [Related]

  • 17. Comparative studies on trypomastigotes of Trypanosoma cruzi from infected mouse blood and infected fibroblast cell (L-cell) culture.
    Kanbara H, Nakabayashi T.
    Biken J; 1983 Mar 01; 26(1):57-62. PubMed ID: 6414455
    [Abstract] [Full Text] [Related]

  • 18. gp72, the 72 kilodalton glycoprotein, is the membrane acceptor site for C3 on Trypanosoma cruzi epimastigotes.
    Joiner K, Hieny S, Kirchhoff LV, Sher A.
    J Exp Med; 1985 May 01; 161(5):1196-212. PubMed ID: 3886827
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of platelets and complement in the clearance of epimastigote forms of Trypanosoma cruzi.
    Umekita LF, Piazza RM, Mota I.
    Braz J Med Biol Res; 1994 Oct 01; 27(10):2391-9. PubMed ID: 7640629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.